HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment.

Abstract
Treatment with plasma exchange, steroids, immunosuppressant drugs and cytotoxic chemotherapy was effective in two cases of cancer-associated Eaton-Lambert myasthenic syndrome. The clinical improvement noted during treatment was accompanied by improvement in the electrophysiological abnormality; this was much more marked in abductor digiti minimi and trapezius than in extensor digitorum brevis.
AuthorsD A Ingram, G R Davis, M S Schwartz, M Traub, A C Newland, M Swash
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 47 Issue 8 Pg. 806-12 (Aug 1984) ISSN: 0022-3050 [Print] England
PMID6088701 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Prednisolone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Small Cell (complications, drug therapy)
  • Combined Modality Therapy
  • Electromyography
  • Humans
  • Lung Neoplasms (complications, drug therapy)
  • Male
  • Middle Aged
  • Myasthenia Gravis (diagnosis, therapy)
  • Plasma Exchange
  • Prednisolone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: